top of page
Managing Organ Rejection Through Innovative Solutions
"Long before anyone else, Paul Terasaki was interested in the use of specific antilymphocyte antibodies to treat rejection…" March 2016
Thomas E. Starzl, MD, PhD
Professor of Surgery
University of Pittsburgh
"Paul Terasaki’s 1964 article in Nature
on the Lymphocytotoxicty Assay was the beginning of personalized medicine something that is now quite vogue to talk about was actually invented by Paul Terasaki 55 years ago…" July 2019
Allan Kirk, MD, PHD
Chair, Department of Surgery
Duke University
bottom of page